The CFX Connect system, which requires a computer for operation, offers the same thermal performance as the CFX96 Touch™ real-time PCR system. It uses a similar scanning optics shuttle design that reads each well individually with high sensitivity and no cross talk to deliver optimal quantitative results. The CFX Connect detects two fluorophores per well in duplex experiments and detects SYBR® Green or EvaGreen® in singleplex experiments.

Additional key benefits:

    * Effortless optimization — saves time and reduces costs by optimizing assays in a single run using the thermal gradient
    * Accurate data analysis — CFX Manager™ software offers an intuitive user interface and the ability to quickly and accurately validate and analyze data
    * Accelerated publication submission — provides minimum information for publication of quantitative real-time PCR experiments (MIQE) annotations and real-time PCR data markup language (RDML) files using Biogazelle’s qbasePLUS software

To learn more about the CFX Connect, visit

About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, and major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs more than 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, please visit